A Biopharmaceutical and Wellness Company

Michael Nashat has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to joining TerrAscend, Mr. Nashat was the Executive Director of OnPharm Independent Pharmacy Group, which represents over 300 pharmacies. A former board member of Ontario College of Pharmacists, Canadian Association of Chain Drug Stores and the Ontario Ministry of Health and Long-Term Care’s Pharmacy Council.

Matthew Johnson, a seasoned healthcare industry executive with over 25 years of experience, has held multiple senior-level positions with several large medical device and pharmaceutical companies. Most recently, he led the AbbVie Transition Office and was responsible for managing enterprise-wide transformation efforts, including merger integration. Prior to this, he headed Global Alliance Management within Abbott’s pharmaceuticals division where he drove collaboration strategy planning, alignment and communication among project teams for all of Abbott’s partnered pipeline products. He also held senior leadership roles at Brunswick Corporation and Baxter Healthcare Corporation.

Adam Kozak recently joined TerrAscend as Chief Financial Officer. He brings with him a wealth of experience from Loblaw Companies Limited.  During his 10-year tenure, Adam led initiatives in mergers and integration, process re-engineering and analytics. Prior to Loblaw, Adam also held positions at Deloitte and Wormald Masse Keen Lopinski.

Robyn Rabinovich is a business development professional with extensive experience in the cannabis space. Her knowledge supports her ability to evaluate business development opportunities within Canada and across the globe. Robyn obtained her International Business Degree from Dalhousie University.

Ari Unterman was formerly a corporate lawyer with experience in corporate and technology law. He has also participated in entrepreneurial and start up ventures, including supporting an early stage legal technology start up. Ari obtained his BA in Political Science at Western University and his JD/MBA at the University of Windsor.

Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the specialty pharmaceutical sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy where he received a bachelor’s degree in Pharmacy.

Michael Nashat has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to joining TerrAscend, Mr. Nashat was the Executive Director of OnPharm Independent Pharmacy Group, which represents over 300 pharmacies. A former board member of Ontario College of Pharmacists, Canadian Association of Chain Drug Stores and the Ontario Ministry of Health and Long-Term Care’s Pharmacy Council.

Richard Mavrinac held positions as CFO for George Weston Limited and Executive VP of Loblaw Companies and has extensive expertise in public company finance and strategy.

Gopal Bhatnagar is the co-founder of one of the largest e-cigarette suppliers and retailers in Canada, 180° Smoke and is an Adjunct Assistant Professor of Surgery at University of Toronto. He is the former Chief of Staff and former Head of the Cardiovascular Surgery Unit at Trillium Hospital. He currently serves as Head of the Cardiac Surgery Division at Cleveland Clinic, Abu Dhabi.

Craig Collard is the CEO of Veloxis Pharmaceuticals, a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patient and has over 20 years of experience in the pharmaceutical industry. Mr. Collard has a proven track-record of leadership, managing organizational change, and driving successful merger and acquisition activity. Prior to Veloxis, Mr. Collard was the Founder and CEO of Cornerstone Therapeutics, a company focused on hospital, respiratory and adjacent specialty markets.